1. Yabroff, K. & Schrag, D. J. Natl. Cancer Inst. 101, 1161–1163 (2009).
2. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the Twenty-First Century (National Academy of Sciences, Washington, DC, 2001).
3. Mulcahy, N. Time to consider cost in evaluating cancer drugs in the United States? < http://www.medscape.com/viewarticle/705689 > (2009).
4. Fojo, T. & Grady, C. J. Natl. Cancer Inst. 101, 1044–1048 (2009).
5. Anonymous. CDC Faststats (Centers for Disease Control and Prevention, Washington, DC, USA) < http://www.cdc.gov/nchs/FASTATS/cancer.htm > (Accessed, November 1, 2009).